The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Regulation and Function of the PD-L1 Checkpoint
Open accessAbstract
Expression of programmed death-ligand 1 (PD-L1) is frequently observed in human cancers. Binding of PD-L1 to its receptor PD-1 on activated T cells inhibits anti-tumor immunity by counteracting T cell-activating signals. Antibody-based PD-1-PD-L1 inhibitors can induce durable tumor remissions in patients with diverse advanced cancers, and thus expression of PD-L1 on tumor cells and other cells in the tumor microenviroment is of major clinical relevance. Here we review the roles of the PD-1-PD-L1 axis in cancer, focusing on recent findings on the mechanisms that regulate PD-L1 expression at the transcriptional, posttranscriptional, and protein level. We place this knowledge in the context of observations in the clinic and discuss how it may inform the design of more precise and effective cancer immune checkpoint therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–231 of 231
Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer
George, J., Saito, M., Tsuta, K., Iwakawa, R., Shiraishi, K., Scheel, A. H., Uchida, S., WATANABE, S.-I. I., Nishikawa, R., Noguchi, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1069 · Cited by 108
Suppressed T-cell activation by IFN- -induced expression of PD-L1 on renal tubular epithelial cells
Schoop, R., Wahl, P., Hir, M. L., Heemann, U., Wang, M., & Wüthrich, R. P. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh423 · Cited by 107
TLR4 Signaling Induces B7-H1 Expression Through MAPK Pathways in Bladder Cancer Cells
Qian, Y., Deng, J., Geng, L., Xie, H., Jiang, G., Zhou, L., Wang, Y., Yin, S., Feng, X., Liu, J., et al. (2008) · Cancer Investigation · doi:10.1080/07357900801941852 · Cited by 104
Matta, B. M., Raimondi, G., Rosborough, B. R., Sumpter, T. L., & Thomson, A. W. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103382 · Cited by 101
Huang, G., Wen, Q., Zhao, Y., Gao, Q., & Bai, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061602 · Cited by 96
Zhao, Q., Xiao, C., Wu, Y., Wei, Y., Zhu, L., Zhou, J., & Kuang, D. (2011) · European Journal of Immunology · doi:10.1002/eji.201041282 · Cited by 95
Cutting Edge: IFN-γ Enables APC to Promote Memory Th17 and Abate Th1 Cell Development
Kryczek, I., Wei, S., Gong, W., Shu, X., Szeliga, W., Vatan, L., Chen, L., Wang, G., & Zou, W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5842 · Cited by 93
Yang, L., Huang, F., Mei, J., Wang, X., Zhang, Q., Wang, H., Xi, M., & You, Z. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000875 · Cited by 93
IL-27 renders DC immunosuppressive by induction of B7-H1
Karakhanova, S., Bedke, T., Enk, A., & Mahnke, K. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1209788 · Cited by 92
Cioffi, M., Trabulo, S. M. D., Vallespinós, M., Raj, D., Kheir, T. B., Lin, M.-L., Begum, J., Baker, A., Amgheib, A., Saif, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15450 · Cited by 90
Interferon-γ engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein
Lekmine, F., Sassano, A., Shahab Uddin, M. S., Smith, J., Majchrzak, B., Brachmann, S. M., Hay, N., Fish, E. N., & Platanias, L. C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.021 · Cited by 88
Song, S., Yuan, P., Wu, H., Chen, J., Fu, J., Li, P., Lu, J., & Wei, W. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.027 · Cited by 84
Cryptosporidium parvumInduces B7‐H1 Expression in Cholangiocytes by Down‐Regulating MicroRNA‐513
Gong, A., Zhou, R., Hu, G., Liu, J., Sosnowska, D., Drescher, K. M., Dong, H., & Chen, X. (2009) · The Journal of Infectious Diseases · doi:10.1086/648589 · Cited by 82
NI, X. Y., Sui, H. X., Liu, Y., Ke, S. Z., Wang, Y. N., & GAO, F. G. (2012) · Oncology Reports · doi:10.3892/or.2012.1822 · Cited by 81
TNF-α and TGF-β Counter-Regulate PD-L1 Expression on Monocytes in Systemic Lupus Erythematosus
Ou, J.-N., WIEDEMAN, A. E., & Stevens, A. M. (2012) · Scientific Reports · doi:10.1038/srep00295 · Cited by 77
Quandt, D., Jasinski‐Bergner, S., Müller, U., Schulze, B., & Seliger, B. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-151 · Cited by 75
TLR3 triggering regulates PD-L1 (CD274) expression in human neuroblastoma cells
Boes, M. L., & Meyer‐Wentrup, F. A. G. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.027 · Cited by 72
Xie, G., Li, W., Li, R., Wu, K., Zhao, E., Zhang, Y., Zhang, P., Shi, L., Wang, D., Yin, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168822 · Cited by 70
Karakhanova, S., Meisel, S., Ring, S., Mahnke, K., & Enk, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200939289 · Cited by 62
Erkes, D. A., Smith, C. J., Wilski, N. A., Caldeira-Dantas, S., Mohgbeli, T., & Snyder, C. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601064 · Cited by 55
miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression
Miao, S., Mao, X., Zhao, S., Song, K., Xiang, C., Lv, Y., Jiang, H., Wang, L., Li, B., Yang, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19121 · Cited by 54
Gauen, L. K. T., Zhu, Y., Letourneur, F., Hu, Q., Bolen, J. B., Matis, L. A., Klausner, R. D., & Shaw, A. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3729-3741.1994 · Cited by 50
Bellone, S., Buza, N., Choi, J., Zammataro, L. A., Gay, L. M., Elvin, J. A., Rimm, D. L., Liu, Y., Ratner, E., Schwartz, P. E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1805 · Cited by 49
Muthumani, K., Shedlock, D. J., Choo, D. K., Fagone, P., Kawalekar, O. U., Goodman, J., Bian, C. B., Ramanathan, A. A., Atman, P., Tebas, P., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100594 · Cited by 40
Seliger, B. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2013.875084 · Cited by 39
Starke, A., Wuthrich, R. P., & Waeckerle‐Men, Y. (2007) · Nephron Experimental Nephrology · doi:10.1159/000106506 · Cited by 36
Ugi, S., Maegawa, H., Olefsky, J. M., Shigeta, Y., & Kashiwagi, A. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80141-x · Cited by 35
Type Iγ phosphatidylinositol phosphate kinase regulates PD-L1 expression by activating NF-κB
Xue, J., Chen, C., Qi, M., Huang, Y., Wang, L., Gao, Y., Dong, H., & Ling, K. (2017) · Oncotarget · doi:10.18632/oncotarget.17123 · Cited by 32
Xiong, H.-Y., Ma, T., Wu, B., Lin, Y., & Tu, Z. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.14.5767 · Cited by 31
Yamamoto, H., Yamashita, K., & Perucho, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.24497 · Cited by 22
Minchom, A. R., Thavasu, P., Ahmad, Z., Stewart, A., Georgiou, A., O'Brien, M. E. R., Popat, S., Bhosle, J., Yap, T. A., Bono, J. S. D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186106 · Cited by 22
Cited by
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
Cancer immunoediting and resistance to T cell-based immunotherapy
O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Doroshow, D. B., Bhalla, S., Beasley, M. B., Sholl, L. M., Kerr, K. M., Gnjatic, S., Wistuba, I. I., Rimm, D. L., Tsao, M. S., & Hirsch, F. R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00473-5 · Cited by 1,575
Tumour-intrinsic resistance to immune checkpoint blockade
Kalbasi, A., & Ribas, A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0218-4 · Cited by 1,486
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Tang, R., Xu, J., Zhang, B., Liu, J., Liang, C., Hua, J., Meng, Q., Yu, X., & Shi, S. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00946-7 · Cited by 1,273
Metadata
- Authors
- Sun, C., Mezzadra, R., & Schumacher, T. N.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 48
- Issue
- 3
- Pages
- 434-452
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2790574591
- Cited by
- 2,193
- References
- 231
- FWCI
- 62.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.